Sarepta Therapeutics, a biotech company, hit a rough patch. The FDA forced a pause on its gene therapy trials for Elevidys, causing Sarepta shares to drop fast. This news shook the stock market and left investors and patients worried.
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
CLVFA stock at $3.00 on PNK shows volume spike and oversold bounce setup with modest upside forecasts
Intraday look at TER stock on 02 Mar 2026 — price $322.86, PE 92.49, outlook and Meyka AI forecast for investors
In July 2025, Ark Invest made headlines again. This time, it wasn’t for buying, it was for selling. The firm sold $12 million worth of Coinbase shares. That’s a big deal. Coinbase has long been one of Ark’s top crypto picks. So why the change? Continue Reading on Meyka This article is available in full…
Nvidia stock jumped about 2% on Monday, bringing the AI-chip giant closer to its all-time high. This positive movement has reignited investor excitement as tech stocks continue to rally. Nvidia’s gains followed recent market dips and were powered by renewed optimism in the artificial intelligence space, particularly from global developments. Continue Reading on Meyka This…
GWH-WT stock drops in pre-market on 12 Feb 2026. Meyka AI analysis, grade and forecast for GWH-WT stock.
Volume spike pushes EBML stock down -29.41% on 16 Jan 2026; liquidity, valuation and Meyka AI forecast reviewed